STEM CELL MANUFACTURING MARKET ANALYSIS

Stem Cell Manufacturing Market, By Type (Product, Services), By Application (Stem Cell Therapy, Drug Discovery and Development, Stem Cell Banking), By End-User (Pharmaceutical and Biotechnology Companies & CRO, Cell Banks and Tissue Banks, Academic & Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2024
Code : CMI5381
Pages :168
Formats :
Excel and PDF
Industry : Biotechnology

Market Concentration and Competitive Landscape

Stem Cell Manufacturing Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Rise in the number of approvals partnerships relating to stem cell therapy

The market is anticipated to experience growth driven by an increase in approvals and partnerships related to stem cell therapy. For instance, in March 2021, Vertex Pharmaceuticals obtained FDA fast-track designation for VX-880, a human stem cell-derived therapy intended for patients with Type 1 diabetes. VX-880 represents a pioneering allogeneic, fully differentiated islet cell therapy aimed at regulating glucose levels by reinstating pancreatic islet cell function, including insulin production.

Key Players Insights